Listeria-based immunotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Listeria-based immunotherapy, covering 2024-05-03 to 2024-05-03. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant Listeria or Daratumumab in Prostate Cancer [Phase 2]